The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England
Open accessPublished version of a preprint
Abstract
The SARS-CoV-2 lineage B.1.1.7, designated variant of concern (VOC) 202012/01 by Public Health England 1, was first identified in the UK in late summer to early autumn 2020 2. Whole-genome SARS-CoV-2 sequence data collected from community-based diagnostic testing for COVID-19 show an extremely rapid expansion of the B.1.1.7 lineage during autumn 2020, suggesting that it has a selective advantage. Here we show that changes in VOC frequency inferred from genetic data correspond closely to changes inferred by S gene target failures (SGTF) in community-based diagnostic PCR testing. Analysis of trends in SGTF and non-SGTF case numbers in local areas across England shows that B.1.1.7 has higher transmissibility than non-VOC lineages, even if it has a different latent period or generation time. The SGTF data indicate a transient shift in the age composition of reported cases, with cases of B.1.1.7 including a larger share of under 20-year-olds than non-VOC cases. We estimated time-varying reproduction numbers for B.1.1.7 and co-circulating lineages using SGTF and genomic data. The best-supported models did not indicate a substantial difference in VOC transmissibility among different age groups, but all analyses agreed that B.1.1.7 has a substantial transmission advantage over other lineages, with a 50% to 100% higher reproduction number.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Epidemiological studies suggest that it was approximately 50% more transmissible than previously circulating UK variants 191,197,198 .”
From The biological and clinical significance of emerging SARS-CoV-2 variants (2021) · cites this paper as [191]
In the citing paper
“Volz and colleagues have shown that the B.1.1.7 variant increases the effective reproduction number, Rt, by a factor of 1·5–2·0.5”
From Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study (2021) · cites this paper as [5]
In the citing paper
“Preliminary evidence from epidemiological studies suggests that the B.1.1.7 variant is more transmissible than pre-existing variants.”
From Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study (2021) · cites this paper as [5]
In the citing paper
“In addition, the emergence of new variants with increased transmissibility 8 and reduced sensitivity to vaccine-elicited antibodies 9 , and for which vaccines are less able to prevent infection 10 , has raised fears for vulnerable groups in whom the magnitude and quality of immune responses may be suboptimal.”
From Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2 (2021) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Elements of Statistical Learning
Hastie, T., Tibshirani, R., & Friedman, J. (2009) · Springer Series in Statistics · doi:10.1007/978-0-387-84858-7 · Cited by 25,970
IQ-TREE 2: New Models and Efficient Methods for Phylogenetic Inference in the Genomic Era
Minh, B. Q., Schmidt, H. A., Chernomor, O., Schrempf, D., Woodhams, M. D., von Haeseler, A., & Lanfear, R. (2020) · Molecular Biology and Evolution · doi:10.1093/molbev/msaa015 · Cited by 16,873
Hastie, T., & Tibshirani, R. (1986) · Statistical Science · doi:10.1214/ss/1177013604 · Cited by 12,575
Posterior summarization in Bayesian phylogenetics using tracer 1.7
Rambaut, A., Drummond, A. J., Xie, D., Baele, G., & Suchard, M. A. (2018) · Systematic Biology · doi:10.1093/sysbio/syy032 · Cited by 11,159
Self-citationBayesian phylogenetic and phylodynamic data integration using BEAST 1.10
Suchard, M. A., Lemey, P., Baele, G., Ayres, D. L., Drummond, A. J., & Rambaut, A. (2018) · Virus Evolution · doi:10.1093/ve/vey016 · Cited by 3,749
Self-citationEstimating the effects of non-pharmaceutical interventions on COVID-19 in Europe
Flaxman, S. R., Mishra, S., Gandy, A., Unwin, H. J. T., Mellan, T. A., Coupland, H., Whittaker, C., Zhu, H., Berah, T., Eaton, J. W., et al. (2020) · Nature · doi:10.1038/s41586-020-2405-7 · Cited by 3,398
Self-citationEstimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Davies, N. G., Abbott, S., Barnard, R. C., Jarvis, C. I., Kucharski, A. J., Munday, J. D., Pearson, C. A. B., Russell, T. W., Tully, D. C., Washburne, A. D., et al. (2021) · Science · doi:10.1126/science.abg3055 · Cited by 2,581
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Davies, N. G., Abbott, S., Barnard, R. C., Jarvis, C. I., Kucharski, A. J., Munday, J. D., Pearson, C. A. B., Russell, T. W., Tully, D. C., Washburne, A. D., et al. (2020) · doi:10.1101/2020.12.24.20248822 · Cited by 2,557
Detection of a SARS-CoV-2 variant of concern in South Africa
Tegally, H., Wilkinson, E., Giovanetti, M., Iranzadeh, A., Fonseca, V., Giandhari, J., Doolabh, D., Pillay, S., San, E. J., Msomi, N., et al. (2021) · Nature · doi:10.1038/s41586-021-03402-9 · Cited by 2,510
Bi, Q., Wu, Y., Mei, S., Ye, C., Zou, X., Zhang, Z., Liu, X., Wei, L., Truelove, S., Zhang, T., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30287-5 · Cited by 1,960
Cited by
Sorted by citations
Items 701–800 of 1,003
Bozidis, P., Tsaousi, E., Kostoulas, C., Sakaloglou, P., Gouni, A., Koumpouli, D., Sakkas, H., Georgiou, I. A., & Gartzonika, K. (2022) · Diagnostics · doi:10.3390/diagnostics12040973 · Cited by 15
Anatomy of the first six months of COVID-19 vaccination campaign in Italy
Gozzi, N., Chinazzi, M., Davis, J. T., Mu, K., y Piontti, A. P., Ajelli, M., Perra, N., & Vespignani, A. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010146 · Cited by 16
COVID-19 vaccines: Update of the vaccines in use and under development
Marta, R. A., Nakamura, G. E. K., Aquino, B. D. M., & Bignardi, P. R. (2022) · Vacunas (English Edition) · doi:10.1016/j.vacun.2022.06.003 · Cited by 16
Hinch, R., Panovska‐Griffiths, J., Probert, W. J. M., Luca Ferretti, A., Wymant, C., Lauro, F. D., Baya, N. A., Ghafari, M., Abeler‐Dörner, L., The COVID-19 Genomics UK (COG-UK) Consortium, et al. (2022) · Philosophical Transactions of the Royal Society A Mathematical Physical and Engineering Sciences · doi:10.1098/rsta.2021.0304 · Cited by 14
Self-citationEpidemic Spread of SARS-CoV-2 Lineage B.1.1.7 in Brazil
Moreira, F. R. R., Menezes, D., Zauli, D. A. G., Silva, J. D. P., de Lima, A. B., Malta, F. S. V., Ferreira, A. C. D. S., Pardini, V. C., Magalhães, W. C. S., Queiroz, D. C., et al. (2021) · Viruses · doi:10.3390/v13060984 · Cited by 15
Cosentino, G., Bernard, M., Ambroise, J., Giannoli, J., Guedj, J., Débarre, F., & Blanquart, F. (2021) · Journal of Infection · doi:10.1016/j.jinf.2021.07.031 · Cited by 13
N’Guessan, A., Tsitouras, A., Sanchez-Quete, F., Goitom, E., Reiling, S. J., Gálvez, J. H., Nguyen, T. L., Nguyen, H. T. L., Visentin, F., Hachad, M., et al. (2022) · medRxiv · doi:10.1101/2022.02.01.22270170 · Cited by 15
Quiroga, S. A., Hernández, C., Castañeda, S., Jiménez, P., Vega, L., Gómez, M., Martinez, D., Ballesteros, N., Muñoz, M., Cifuentes, C., et al. (2021) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-021-00445-8 · Cited by 14
Phylodynamic Inference of Bacterial Outbreak Parameters Using Nanopore Sequencing
Steinig, E. J., Duchêne, S., Aglua, I., Greenhill, A. R., Ford, R. L., Yoannes, M., Jaworski, J., Drekore, J., Urakoko, B., Poka, H., et al. (2022) · Molecular Biology and Evolution · doi:10.1093/molbev/msac040 · Cited by 16
Epidemiology and genetic diversity of SARS-CoV-2 lineages circulating in Africa
Okoh, O. S., Nii-Trebi, N. I., Jakkari, A., Olaniran, T. T., Senbadejo, T. Y., Kafintu-kwashie, A. A., Dairo, E. O., Ganiyu, T. O., Akaninyene, I. E., Ezediuno, L. O., et al. (2022) · iScience · doi:10.1016/j.isci.2022.103880 · Cited by 13
Zabaleta, N., Bhatt, U., Hérate, C., Maisonnasse, P., Sanmiguel, J. C., Diop, C. T., Castore, S., Estelien, R., Li, D., Dereuddre‐Bosquet, N., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.05.007 · Cited by 17
Rapid and Flexible RT-qPCR Surveillance Platforms To Detect SARS-CoV-2 Mutations
Spieß, K., Gunalan, V., Marving, E. L., Nielsen, S. H., Jørgensen, M. G. P., Fomsgaard, A. S., Nielsen, L., Alfaro‐Núñez, A., Karst, S. M., Mortensen, S., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.03591-22 · Cited by 24
Noahsen, P., Faber, L. L., Isidor, S., Fonager, J., Rasmussen, M., & Hansen, H. L. (2023) · Eurosurveillance · doi:10.2807/1560-7917.es.2023.28.29.2200767 · Cited by 14
Prediction models for COVID-19 disease outcomes
Tang, C. Y., Gao, C., Prasai, K., Li, T., Dash, S., McElroy, J. A., Hang, J., & Wan, X. (2024) · Emerging Microbes & Infections · doi:10.1080/22221751.2024.2361791 · Cited by 19
de Souza, U. J. B., Spilki, F. R., Tanuri, A., Roehe, P. M., & Campos, F. S. (2025) · Viruses · doi:10.3390/v17010064 · Cited by 14
Buenestado‐Serrano, S., Recio, R., Sola‐Campoy, P. J., Catalán, P., Folgueira, M. D., Villa, J., Gallego, I. M., de la Cueva, V. M., Meléndez, M. Á., Andrés-Zayas, C., et al. (2021) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2021.02.006 · Cited by 14
Orellana, J. D. Y., Marrero, L., & Horta, B. L. (2021) · Epidemiologia e Serviços de Saúde · doi:10.1590/s1679-49742021000400024 · Cited by 14
An overview of the National COVID-19 Chest Imaging Database: data quality and cohort analysis
Cushnan, D., Bennett, O., Berka, R., Bertolli, O., Chopra, A., Dorgham, S., Favaro, A., Ganepola, T., Halling‐Brown, M., Imreh, G., et al. (2021) · GigaScience · doi:10.1093/gigascience/giab076 · Cited by 14
Hassanin, A. A., Raza, S. H. A., Ujan, J. A., ALrashidi, A. A., Sitohy, B., AL-surhanee, A. A., Saad, A. M., Al-Hazani, T. M. I., Atallah, O. O., Syaad, K. M. A., et al. (2021) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2021.12.020 · Cited by 14
Robust clinical detection of SARS‐CoV‐2 variants by RT‐PCR/MALDI‐TOF multitarget approach
Hernandez, M. M., Banu, R., Gonzalez-Reiche, A. S., van de Guchte, A., Khan, Z., Shrestha, P., Cao, L., Chen, F., Shi, H., Hanna, A., et al. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27510 · Cited by 14
Prince, T., Dong, X., Penrice-Randal, R., Randle, N., Hartley, C. S., Goldswain, H., Jones, B., Semple, M. G., Baillie, J. K., Openshaw, P., et al. (2022) · mSphere · doi:10.1128/msphere.00913-21 · Cited by 14
Kaiser, A. K., Kretschmer, D., & Leszczensky, L. (2021) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2021.100166 · Cited by 14
Global landscape of the host response to SARS-CoV-2 variants reveals viral evolutionary trajectoriesPreprint
Bouhaddou, M., Reuschl, A., Polacco, B. J., Thorne, L., Ummadi, M. R., Ye, C., Rosales, R., Pelin, A., Batra, J., Jang, G. Μ., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.19.512927 · Cited by 14
Yang, J., Cui, Y., Yu, D., Zhang, G., Cao, R., Gu, Z., Dai, G., Wu, X., Ling, Y., Yi, C., et al. (2023) · Molecular Biology and Evolution · doi:10.1093/molbev/msad142 · Cited by 15
van der Toorn, W., Oh, D., & von Kleist, M. (2021) · Patterns · doi:10.1016/j.patter.2021.100264 · Cited by 13
Progressing adaptation of SARS-CoV-2 to humans
Konishi, T. (2022) · Chem-Bio Informatics Journal · doi:10.1273/cbij.22.1 · Cited by 13
Setz, C., Große, M., Auth, J., Fröba, M., Rauch, P., Bausch, A., Wright, M. B., & Schubert, U. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126830 · Cited by 15
One-Year Surveillance of SARS-CoV-2 Exposure in Stray Cats and Kennel Dogs from Northeastern Italy
Bellinati, L., Campalto, M., Mazzotta, E., Ceglie, L., Cavicchio, L., Mion, M. M., Lucchese, L., Salomoni, A., Bortolami, A., Quaranta, E. G., et al. (2022) · Microorganisms · doi:10.3390/microorganisms11010110 · Cited by 13
Widera, M., Mühlemann, B., Corman, V. M., Toptan, T., Beheim-Schwarzbach, J., Kohmer, N., Schneider, J. A., Berger, A., Veith, T., Pallas, C., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9040748 · Cited by 13
SARS-CoV-2: Unique Challenges of the Virus and Vaccines
Mahmoodpoor, A., Sanaie, S., Samadi, P., Yousefi, M., & Nader, N. D. (2021) · Immunological Investigations · doi:10.1080/08820139.2021.1936009 · Cited by 12
Genomic and Epidemiological Analysis of SARS-CoV-2 Viruses in Sri Lanka
Jeewandara, C., Jayathilaka, D., Ranasinghe, D. M. S. H. K., Hsu, S. N., Ariyaratne, D., Jayadas, T. T. P., Madusanka, D., Lindsey, B. B., Gomes, L., Parker, M. D., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.722838 · Cited by 13
Yue, S., Li, Z., Lin, Y., Yang, Y., Yuan, M., Pan, Z., Li, H., Gao, L., Zhou, J., Tang, J., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.751584 · Cited by 13
Transmissibility and pathogenicity of SARS-CoV-2 variants in animal models
Kim, Y., Casel, M. A. B., & Choi, Y. K. (2022) · The Journal of Microbiology · doi:10.1007/s12275-022-2033-z · Cited by 14
Recapping the Features of SARS-CoV-2 and Its Main Variants: Status and Future Paths
Ortega, M. A., Montero, C. G., Fraile‐Μartinez, O., Colet, P. C., Baizhaxynova, A., Mukhtarova, K., Álvarez‐Mon, M., Kanatova, K., Asúnsolo, Á., & Sarría‐Santamera, A. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12060995 · Cited by 12
Global estimates of the fitness advantage of SARS-CoV-2 variant Omicron
van Dorp, C. H., Goldberg, E. E., Ke, R., Hengartner, N., & Romero-Severson, E. O. (2022) · Virus Evolution · doi:10.1093/ve/veac089 · Cited by 13
Kurpas, M. K., Jaksik, R., Kuś, P., & Kimmel, M. (2022) · Viruses · doi:10.3390/v14112375 · Cited by 13
Sava, C. N., Bodog, T. M., Niulaș, L., Iuhas, A., Marinău, C., Negruţ, N., Balmoș, A., Pașca, B., Roman, N. A., & Nistor-Cseppento, C. D. (2022) · In Vivo · doi:10.21873/invivo.13019 · Cited by 15
Potent SARS-CoV-2 neutralizing antibodies with therapeutic effects in two animal models
Takeshita, M., Fukuyama, H., Kamada, K., Matsumoto, T., Makino‐Okamura, C., Uchikubo‐Kamo, T., Tomabechi, Y., Hanada, K., Moriyama, S., Takahashi, Y., et al. (2022) · iScience · doi:10.1016/j.isci.2022.105596 · Cited by 13
Xu, R., Wang, W., & Zhang, W. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.1039123 · Cited by 12
COVID-19: A state of art on immunological responses, mutations, and treatment modalities in riposte
Gong, X., Khan, A., Wani, M. Y., Ahmad, A., & Duse, A. G. (2022) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2022.12.019 · Cited by 15
Majeed, B. J., David, J., Bragazzi, N. L., McCarthy, Z., Grunnill, M. D., Heffernan, J. M., Wu, J., & Woldegerima, W. A. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2022.1086849 · Cited by 14
Factor Xa cleaves SARS-CoV-2 spike protein to block viral entry and infection
Dong, W., Wang, J., Tian, L., Zhang, J., Settles, E. W., Qin, C., Kollath, D. R., Itogawa, A. N., Celona, K. R., Yi, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37336-9 · Cited by 13
Farès, W., Ghedira, K., Gdoura, M., Chouikha, A., Boubaker, S., Khedhiri, M., Ayouni, K., Lamari, A., Touzi, H., Hammemi, W., et al. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00639-21 · Cited by 13
Cohort profile: Actionable Register of Geneva Outpatients and inpatients with SARS-CoV-2 (ARGOS)
Genecand, C., Mongin, D., Koegler, F., Lebowitz, D., Regard, S., Falcone, J.-L., Nehme, M., Braillard, O., Grira, M., Joubert, D., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-048946 · Cited by 12
Bui, N.-N., Lin, Y.-T., Huang, S.-H., & Lin, C. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.105164 · Cited by 13
Genomic Epidemiology of Early SARS-CoV-2 Transmission Dynamics, Gujarat, India
Raghwani, J., du Plessis, L., McCrone, J. T., Hill, S. C., Parag, K. V., Thézé, J., Kumar, D., Puvar, A., Pandit, R. J., Pybus, O. G., et al. (2022) · Emerging infectious diseases · doi:10.3201/eid2804.212053 · Cited by 13
Self-citationBrown, K. A., Tibebu, S., Daneman, N., Schwartz, K. L., Whelan, M., & Buchan, S. A. (2021) · medRxiv · doi:10.1101/2021.06.03.21258302 · Cited by 13
Global Expansion of SARS-CoV-2 Variants of Concern: Dispersal Patterns and Influence of Air TravelPreprint
Tegally, H., Wilkinson, E., Martin, D. P., Moir, M., Brito, A. F., Giovanetti, M., Khan, K., Huber, C., Bogoch, I. I., San, J. E., et al. (2022) · medRxiv · doi:10.1101/2022.11.22.22282629 · Cited by 13
Leung, L. Y. T., Khan, S., Budylowski, P., Li, Z., Goroshko, S., Liu, Y., Dong, S., Carlyle, J. R., Rini, J. M., Ostrowski, M., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.659071 · Cited by 13
Immunology and Technology of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines
Pecetta, S., Kratochvil, S., Kato, Y., Vadivelu, K., & Rappuoli, R. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000285 · Cited by 11
Bhatia, S., Wardle, J., Nash, R. K., Nouvellet, P., & Cori, A. (2023) · Epidemics · doi:10.1016/j.epidem.2023.100692 · Cited by 15
Hermet, P., Delache, B., Hérate, C., Wolf, E., Kivi, G., Juronen, E., Mumm, K., Žusinaite, E., Kainov, D. E., Sankovski, E., et al. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011532 · Cited by 13
SARS-CoV-2 genomics and impact on clinical care for COVID-19
Lorenzo-Redondo, R., Carvalho, A. M. D. S., Hultquist, J. F., & Ozer, E. A. (2023) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkad309 · Cited by 12
mRNA Vaccines Against COVID-19 as Trailblazers for Other Human Infectious Diseases
Brandi, R., Paganelli, A., D’Amelio, R., Giuliani, P., Lista, F. R., Salemi, S., & Paganelli, R. (2024) · Vaccines · doi:10.3390/vaccines12121418 · Cited by 13
Modelling the impact of shutdowns on resurging SARS-CoV-2 transmission in Canada
Ng, V., Fazil, A., Waddell, L. A., Turgeon, P., Otten, A., & Ogden, N. H. (2021) · Royal Society Open Science · doi:10.1098/rsos.210233 · Cited by 12
Major Insights in Dynamics of Host Response to SARS-CoV-2: Impacts and Challenges
Hakim, A., Hasan, M. M., Hasan, M., Lokman, S. M., Azim, K. F., Raihan, T., Chowdhury, P. A., & Azad, A. K. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.637554 · Cited by 13
Berg, M. G., Forberg, K., Perez, L. J., Luk, K., Meyer, T. V., & Cloherty, G. (2021) · Viruses · doi:10.3390/v13122534 · Cited by 14
Valley‐Omar, Z., Marais, G. J. K., Iranzadeh, A., Naidoo, M., Korsman, S. N. J., Maponga, T. G., Hussey, H. S., Davies, M., Boulle, A., Doolabh, D., et al. (2022) · Journal of Virological Methods · doi:10.1016/j.jviromet.2022.114471 · Cited by 12
Acer, Ö., Bahçe, Y. G., & Özüdoğru, O. (2022) · Journal of Medical Virology · doi:10.1002/jmv.27677 · Cited by 12
Song, L., Liu, H., Brinkman, F. S. L., Gill, E. E., Griffiths, E., Hsiao, W., Kallesøe, S. S., Moreira, S., Domselaar, G. V., Zawati, M. H., et al. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2021.716541 · Cited by 13
When Successive Viral Mutations Prevent Definitive Treatment of COVID-19
Mohammadi, M. R., & Sabati, H. (2022) · Cellular Molecular and Biomedical Reports · doi:10.55705/cmbr.2022.339012.1040 · Cited by 13
Covid-19 in the UK: policy on children and schools
Gurdasani, D., Pagel, C., McKee, M., Michie, S., Greenhalgh, T., Yates, C. A., Scally, G., & Ziauddeen, H. (2022) · BMJ · doi:10.1136/bmj-2022-071234 · Cited by 14
Estimating the relative proportions of SARS-CoV-2 haplotypes from wastewater samples
Pipes, L., Chen, Z., Afanaseva, S., & Nielsen, R. (2022) · Cell Reports Methods · doi:10.1016/j.crmeth.2022.100313 · Cited by 12
SARS-CoV-2 variants of concern: a review
Sarkar, M. S., & Madabhavi, I. (2022) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2022.2337 · Cited by 14
Steinberg, A. P., Silander, O., & Kussell, E. L. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2206945119 · Cited by 11
Mabuka, T., Naidoo, N., Ncube, N., Yiga, T., Ross, M. D., Kurehwa, K., Nyathi, M. N., Silaji, A., Ndemera, T., Lemeke, T., et al. (2023) · JMIRx Med · doi:10.2196/34598 · Cited by 12
COVID-19 Pandemic in India: Through the Lens of Modeling
Babu, G. R., Ray, D., Bhaduri, R., Halder, A., Kundu, R., Menon, G. I., & Mukherjee, B. (2021) · Global Health Science and Practice · doi:10.9745/ghsp-d-21-00233 · Cited by 13
Czuppon, P., Schertzer, E., Blanquart, F., & Débarre, F. (2021) · Journal of The Royal Society Interface · doi:10.1098/rsif.2021.0575 · Cited by 12
SARS-CoV-2 Portrayed against HIV: Contrary Viral Strategies in Similar Disguise
Duerr, R., Crosse, K. M., Valero-Jimenez, A. M., & Dittmann, M. (2021) · Microorganisms · doi:10.3390/microorganisms9071389 · Cited by 12
Activation Pathways and Free Energy Landscapes of the SARS-CoV-2 Spike Protein
Wu, Y., Qian, R., Yang, Y., Sheng, Y., Li, W., & Wang, W. (2021) · ACS Omega · doi:10.1021/acsomega.1c03384 · Cited by 12
Taher, J., Mighton, C. E., Chowdhary, S., Casalino, S., Frangione, E., Arnoldo, S., Bearss, E., Binnie, A., Bombard, Y., Borgundvaag, B., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-052842 · Cited by 12
Reconstruction of Epidemiological Data in Hungary Using Stochastic Model Predictive Control
Polcz, P., Csutak, B., & Szederkényi, G. (2022) · Applied Sciences · doi:10.3390/app12031113 · Cited by 12
Population Genomics Approaches for Genetic Characterization of SARS-CoV-2 Lineages
Mostefai, F., Gamache, I., N’Guessan, A., Pelletier, J., Huang, J., Murall, C. L., Pesaranghader, A., Gaonac’h-Lovejoy, V., Hamelin, D. J., Poujol, R., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.826746 · Cited by 11
Gaiarsa, S., Giardina, F., Biffignandi, G. B., Ferrari, G., Piazza, A., Tallarita, M., Novazzi, F., Bandi, C., Paolucci, S., Rovida, F., et al. (2022) · Virus Research · doi:10.1016/j.virusres.2022.198786 · Cited by 12
Inferring selection effects in SARS-CoV-2 with Bayesian Viral Allele Selection
Jankowiak, M., Obermeyer, F. H., & Lemieux, J. E. (2022) · PLoS Genetics · doi:10.1371/journal.pgen.1010540 · Cited by 12
Piantham, C., Linton, N. M., Nishiura, H., & Ito, K. (2021) · medRxiv · doi:10.1101/2021.03.17.21253775 · Cited by 12
Impacts on the structure-function relationship of SARS-CoV-2 spike by B.1.1.7 mutationsPreprint
Yang, T., Yu, P., Chang, Y., Liang, K.-H., Tso, H.-C., Ho, M., Wy, C., Lin, H.-T., Wu, H., & Hsu, S. D. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.11.443686 · Cited by 12
Rapid surveillance platforms for key SARS-CoV-2 mutations in DenmarkPreprint
Spieß, K., Gunalan, V., Marving, E. L., Nielsen, S. H., Jørgensen, M. G. P., Fomsgaard, A. S., Nielsen, L., Alfaro‐Núñez, A., Karst, S. M., Mortensen, S., et al. (2021) · medRxiv · doi:10.1101/2021.10.25.21265484 · Cited by 12
Waning, Boosting and a Path to Endemicity for SARS-CoV-2Preprint
Keeling, M. J., Thomas, A. C., Hill, E. M., Thompson, R. N., Dyson, L., Tildesley, M. J., & Moore, S. (2021) · medRxiv · doi:10.1101/2021.11.05.21265977 · Cited by 12
Wohl, S., Lee, E. C., DiPrete, B. L., & Lessler, J. (2022) · medRxiv · doi:10.1101/2021.12.30.21268453 · Cited by 12
Within‐host dynamics of SARS‐CoV‐2 infection: A systematic review and meta‐analysis
Du, Z., Wang, S., Bai, Y., Gao, C., Lau, E. H. Y., & Cowling, B. J. (2022) · Transboundary and Emerging Diseases · doi:10.1111/tbed.14673 · Cited by 11
Velu, P., Cong, L., Rand, S., Qiu, Y., Zhang, Z., Zhang, J., Guo, J., Ruggiero, P., Sukhu, A. C., Fauntleroy, K. A., et al. (2022) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2022.115789 · Cited by 11
Designing In-House SARS-CoV-2 RT-qPCR Assay for Variant of Concerns
Ergören, M. Ç., Tuncel, G., Özverel, C. S., & Şanlıdağ, T. (2022) · Global Medical Genetics · doi:10.1055/s-0042-1756660 · Cited by 11
Variable detection of Omicron-BA.1 and -BA.2 by SARS-CoV-2 rapid antigen tests
Osterman, A., Badell, I., Dächert, C., Schneider, N., Kaufmann, A.-Y., Öztan, G. N., Huber, M., Späth, P. M., Stern, M., Autenrieth, H., et al. (2022) · Medical Microbiology and Immunology · doi:10.1007/s00430-022-00752-7 · Cited by 11
Exploring COVID-19 Recovery Mechanisms of the Accommodation Sector in South Africa
Chihwai, P., & Dube, K. (2023) · Springer eBooks · doi:10.1007/978-3-031-28340-6_16 · Cited by 11
Khetran, S. R., & Mustafa, R. (2023) · JMIR Bioinformatics and Biotechnology · doi:10.2196/43906 · Cited by 13
Evidence of SARS-CoV-2 infection and co-infections in stray cats in Brazil
Castillo, A. P., Miranda, J. V. O., Fonseca, P. L. C., Silva, S. D. O., Lopes, R. E. N., Spanhol, V. C., Moreira, R. G., Nicolino, R. R., Queiroz, D. C., Santos, L. C. G. D. A. E., et al. (2023) · Acta Tropica · doi:10.1016/j.actatropica.2023.107056 · Cited by 11
The impact of spatial connectivity on NPIs effectiveness
Sabbatini, C. E., Pullano, G., Domenico, L. D., Rubrichi, S., Bansal, S., & Colizza, V. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-023-08900-x · Cited by 12
Yu, Q., Ascensao, J. A., Okada, T., Boyd, O., Volz, E., & Hallatschek, O. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012090 · Cited by 11
Self-citationAssessing the role of children in the COVID-19 pandemic in Belgium using perturbation analysis
Angeli, L., Caetano, C., Franco, N., Coletti, P., Faes, C., Molenberghs, G., Beutels, P., Abrams, S., Willem, L., & Hens, N. (2025) · Nature Communications · doi:10.1038/s41467-025-57087-z · Cited by 11
Elsharkawy, A., Jahantigh, H. R., Guglani, A., Stone, S., Arora, K., & Kumar, M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1557535 · Cited by 12
Pokhrel, S., Kraemer, B. R., Lee, L., Samardzic, K., & Mochly‐Rosen, D. (2021) · PLoS ONE · doi:10.1371/journal.pone.0251426 · Cited by 12
Nappi, F., Iervolino, A., & Singh, S. (2021) · Metabolites · doi:10.3390/metabo11060341 · Cited by 11
van Loon, W., Rössig, H., Burock, S., Hofmann, J., Bernhard, J., Linzbach, E., Pettenkofer, D., Schönfeld, C., Gertler, M., Seybold, J., et al. (2021) · Emerging infectious diseases · doi:10.3201/eid2707.210845 · Cited by 11
Latino Household Transmission of Severe Acute Respiratory Syndrome Coronavirus 2
Martínez, D. A., Klein, E. Y., Parent, C., Prieto, D., Bigelow, B. F., Saxton, R. E., & Page, K. R. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab753 · Cited by 11
Boshier, F. A. T., Venturini, C., Stirrup, O., Guerra‐Assunção, J. A., Alcolea-Medina, A., Becket, A. H., Byott, M., Charalampous, T., Filipe, A. D. S., Frampton, D., et al. (2021) · Journal of Infection · doi:10.1016/j.jinf.2021.09.022 · Cited by 11
Verkhivker, G. M., Agajanian, S., Öztaş, D. Y., & Gupta, G. (2021) · ACS Omega · doi:10.1021/acsomega.1c03558 · Cited by 11
A quantitative assessment of epidemiological parameters required to investigate COVID-19 burden
Zardini, A., Galli, M., Tirani, M., Cereda, D., Manica, M., Trentini, F., Guzzetta, G., Marziano, V., Piccarreta, R., Melegaro, A., et al. (2021) · Epidemics · doi:10.1016/j.epidem.2021.100530 · Cited by 10
Phage Display-Derived Compounds Displace hACE2 from Its Complex with SARS-CoV-2 Spike Protein
Sevenich, M. M., Thul, E., Lakomek, N., Klünemann, T., Schubert, M., Bertoglio, F., van den Heuvel, J., Petzsch, P., Mohrlüder, J., & Willbold, D. (2022) · Biomedicines · doi:10.3390/biomedicines10020441 · Cited by 11
Zaykovskaya, A. V., Gladysheva, A. V., Kartashov, M. Y., Taranov, O. S., Ovchinnikova, A. S., Shipovalov, A. V., & Pyankov, O. V. (2022) · Problems of Particularly Dangerous Infections · doi:10.21055/0370-1069-2022-1-94-100 · Cited by 11
Metadata
- Authors
- The COVID-19 Genomics UK (COG-UK) consortium, Volz, E., Mishra, S., Chand, M., Barrett, J. C., Johnson, R., Geidelberg, L., Hinsley, W. R., Laydon, D. J., Dabrera, G., O’Toole, Á., Amato, R., Ragonnet-Cronin, M., Harrison, I., Jackson, B., Ariani, C. V., Boyd, O., Loman, N. J., McCrone, J. T., Gonçalves, S., Jorgensen, D., Myers, R., Hill, V., Jackson, D. K., Gaythorpe, K., Groves, N., Sillitoe, J., Kwiatkowski, D. P., Flaxman, S., Ratmann, O., Bhatt, S., Hopkins, S., Gandy, A., Rambaut, A., & Ferguson, N. M.
- Affiliations
- Imperial College London (GB)
- Public Health England (GB)
- Wellcome Sanger Institute (GB)
- University of Edinburgh (GB)
- University of Copenhagen (DK)
- Corresponding author
- Volz, Erik
- Ferguson, Neil M.
- ORCID
- Volz, Erik
- Mishra, Swapnil
- Chand, Meera
- Barrett, Jeffrey C.
- Geidelberg, Lily
- Hinsley, Wes R.
- Laydon, Daniel J.
- Dabrera, Gavin
- Harrison, Ian
- Jackson, Ben
- Ariani, Cristina V.
- Boyd, Olivia
- Loman, Nicholas J.
- McCrone, John T.
- Gonçalves, Sónia
- Jorgensen, David
- Myers, Richard
- Hill, Verity
- Jackson, David K.
- Gaythorpe, Katy
- Groves, Natalie
- Kwiatkowski, Dominic P.
- Flaxman, Seth
- Ratmann, Oliver
- Bhatt, Samir
- Hopkins, Susan
- Gandy, Axel
- Rambaut, Andrew
- Ferguson, Neil M.
- Venue
- Nature
- Published
- 2021-03-25
- Volume
- 593
- Issue
- 7858
- Pages
- 266-269
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W3136588845
- Cited by
- 1,611
- References
- 32
- Citations by year
- 2026: 38 · 2025: 86 · 2024: 116 · 2023: 216 · 2022: 464 · 2021: 685
- FWCI
- 116.92
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Nature (publishedVersion)
- medRxiv (acceptedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Northumbria Research Link (Northumbria University) (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Spiral (Imperial College London) (submittedVersion, cc-by)
- Spiral (Imperial College London) (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo
- Funders
- Bill and Melinda Gates Foundation (OPP 1175094, 206194, OPP1197730, MR/R015600/1, OPP1084362)
- Wellcome Trust (MR/R015600/1, 204911/Z/16/Z, Z/17/Z, 206298/Z/17/Z, RDA02, 206298, 206194)
- UK Research and Innovation (MR/V038109/1, MR/R015600/1, MC_PC_19027)
- National Institute for Health Research Health Protection Research Unit
- Cancer Research UK (23923)
- National Institute for Health and Care Research (PR-OD-1017–20002, MR/R015600/1, RDA02, NIHR301445, OPP1175094, ACF-2018-04-014)
- Academy of Medical Sciences (AMS-CSF4-Torok, SBF004\1080)
- Imperial College London (MR/R015600/1)
- European Commission (725422, MR/R015600/1, 101003653, COVID-19, 206298/Z/17/Z)
- Rural Development Administration
- Novo Nordisk (NNF20OC0059309)
- Novo Nordisk Fonden (NNF20OC0059309)
- Medical Research Council (MR/R015600/1, MR/M006212/1, MC_PC_19026, MR/V038109/1, MR/S00291X/1, MC_PC_19012, COVID-19)
- Engineering and Physical Sciences Research Council (EP/V002910/1, EP/V002910/2)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 detection and testing
- Keywords
- SARS-CoV-2, B.1.1.7 lineage, variants of concern, transmissibility, S-gene target failure, time-varying reproduction number, viral genomic surveillance, COVID-19 pandemic, England
- MeSH terms
- COVID-19, SARS-CoV-2, Adolescent, Adult, Aged, Aged, 80 and over, Child, Child, Preschool, England, Humans, Infant, Infant, Newborn, Middle Aged, Phylogeny, Time Factors, Genome, Viral, Age Distribution, Evolution, Molecular, Basic Reproduction Number, Young Adult, Spike Glycoprotein, Coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
